These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 10419078)

  • 1. Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension.
    Puig JG; Mateos F; Buño A; Ortega R; Rodriguez F; Dal-Ré R
    J Hypertens; 1999 Jul; 17(7):1033-9. PubMed ID: 10419078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AT1 blockers and uric acid metabolism: are there relevant differences?
    Puig JG; Torres R; Ruilope LM
    J Hypertens Suppl; 2002 Jun; 20(5):S29-31. PubMed ID: 12184060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of eprosartan, an angiotensin II AT1 receptor antagonist, on uric acid excretion in patients with mild to moderate essential hypertension.
    Ilson BE; Martin DE; Boike SC; Jorkasky DK
    J Clin Pharmacol; 1998 May; 38(5):437-41. PubMed ID: 9602957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
    Hedner T; Himmelmann A
    J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome.
    Masajtis-Zagajewska A; Majer J; Nowicki M
    J Renin Angiotensin Aldosterone Syst; 2021; 2021():2214978. PubMed ID: 34527078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group.
    Sega R
    Blood Press; 1999; 8(2):114-21. PubMed ID: 10451039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
    Punzi HA; Punzi CF
    J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.
    Würzner G; Gerster JC; Chiolero A; Maillard M; Fallab-Stubi CL; Brunner HR; Burnier M
    J Hypertens; 2001 Oct; 19(10):1855-60. PubMed ID: 11593107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial.
    Ruilope L; Jäger B; Prichard B
    Blood Press; 2001; 10(4):223-9. PubMed ID: 11800061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension.
    Leu HB; Charng MJ; Ding PY
    Jpn Heart J; 2004 Jul; 45(4):623-35. PubMed ID: 15353873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia.
    Shahinfar S; Simpson RL; Carides AD; Thiyagarajan B; Nakagawa Y; Umans JG; Parks JH; Coe FL
    Kidney Int; 1999 Nov; 56(5):1879-85. PubMed ID: 10571797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group.
    Gradman AH; Gray J; Maggiacomo F; Punzi H; White WB
    Clin Ther; 1999 Mar; 21(3):442-53. PubMed ID: 10321414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the 24-hour blood pressure effects of eprosartan in patients with systemic hypertension.
    White WB; Anwar YA; Mansoor GA; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1248-55. PubMed ID: 11775134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
    Conter HS; McKay DW; Reiz RJ
    Can J Cardiol; 2004 Oct; 20 Suppl C():6C-10C. PubMed ID: 16807617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group.
    Gavras I; Gavras H
    Curr Med Res Opin; 1999; 15(1):15-24. PubMed ID: 10216807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
    Teitelbaum I; Chilvers M; Reiz RJ
    Can J Cardiol; 2004 Oct; 20 Suppl C():11C-16C. PubMed ID: 16807618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide.
    Nikas S; Rizos E; Milionis H; Bairaktari E; Kalaitzidis R; Siamopoulos K; Elisaf M
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):289-91. PubMed ID: 11881040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
    Sachse A; Verboom CN; Jäger B
    J Hum Hypertens; 2002 Mar; 16(3):169-76. PubMed ID: 11896506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.